Yarwood: U.S. must stabilize economy to preserve long-term care, retirement accounts

from McKnight's: 


Congress came to an agreement Wednesday on a $700 bailout package for the faltering financial sector. Such action is good news for long-term care and seniors' retirement accounts, according to Bruce Yarwood, president of the American Health Care Association.

"It's imperative that our nation's leaders address our faltering economy in order to ensure stability for our nation, stability of American jobs, stability for the entire business sector including long-term care and stability of the retirement accounts of hardworking Americans," Yarwood told McKnight's. 


Norman DeLisle, MDRC
"With Liberty and Access for All!"
GrandCentral: 517-589-4081
MDRC Website: http://www.copower.org/
LTC Blog: http://ltcreform.blogspot.com/
Recovery: http://therecoveringlife.blogspot.com/

Aging is a Business and Economic Issue

Like other CEOs, I’m concerned about stemming “brain drain” amid a mass retirement and experience exodus in Minnesota.But a more immediate economic and competitiveness issue is how to deliver and pay for senior care to assist our current employees who are dealing with their aging parents. Absent innovation, the human and financial costs of a much larger, longer-living senior society will weaken other investments designed to enhance Minnesota’s competitiveness and make this state livable for a lifetime.

If my 86-year-old mother-in-law suffered a significant medical event that required care, I would have the luxury of being able to call upon any number of experts within Ecumen for guidance on what to do next, so she could live as fully and independently as possible.

Alzheimer's Growth Shows Need For Increased FDA Funding

A new estimate by the Alzheimer's Association shows that more than five million Americans are living with Alzheimer's disease -- a 10 percent growth over previous estimates and a number that could more than triple in the coming decades unless new treatments and cures are developed for the debilitating illness.

The new numbers re-emphasize the need for a strong and adequately funded drug safety review program at the Food and Drug Administration to ensure that new Alzheimer's disease drugs can be safely and rapidly brought to market, according to the Coalition for a Stronger FDA.